Ramiro Garzon

Active 2005–2024

73
Papers
23,149
Citations
56
h-index
72
i10-index

Citations

Citations per year for Ramiro Garzon1975: 2 citations1986: 2 citations1992: 1 citations1999: 1 citations2002: 2 citations2005: 4 citations2006: 51 citations2007: 132 citations2008: 285 citations2009: 467 citations2010: 617 citations2011: 622 citations2012: 529 citations2013: 513 citations2014: 459 citations2015: 373 citations2016: 275 citations2017: 301 citations2018: 213 citations2019: 859 citations2020: 746 citations2021: 608 citations2022: 378 citations2023: 254 citations2024: 319 citations2025: 133 citations2026: 4 citations1976–1985: no citations, so these years are not shown1987–1991: no citations, so these years are not shown1993–1998: no citations, so these years are not shown2000–2001: no citations, so these years are not shown2003–2004: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,626 citing papers, 29.3% of this breakdownChina: 1,743 citing papers, 19.5% of this breakdownItaly: 529 citing papers, 5.9% of this breakdownGermany: 408 citing papers, 4.5% of this breakdownUnited Kingdom: 324 citing papers, 3.6% of this breakdownIndia: 223 citing papers, 2.5% of this breakdownCanada: 213 citing papers, 2.4% of this breakdownFrance: 205 citing papers, 2.3% of this breakdownJapan: 202 citing papers, 2.2% of this breakdownIran: 179 citing papers, 2% of this breakdownSpain: 178 citing papers, 2% of this breakdownAustralia: 161 citing papers, 1.8% of this breakdown
0%29.3%Other 22%

Fields

  • Biochemistry, Genetics and Molecular Biology72.2%
  • Medicine23.3%
  • Immunology and Microbiology1.9%
  • Neuroscience0.5%
  • Engineering0.3%
  • Materials Science0.3%
  • Other1.5%

Topics

  • MicroRNA in disease regulation18.2%
  • Cancer-related molecular mechanisms research10.2%
  • Circular RNAs in diseases9.4%
  • RNA modifications and cancer4.4%
  • Epigenetics and DNA Methylation3.3%
  • Acute Myeloid Leukemia Research3.3%
  • Other51.2%

Coauthors

All papers

Open in search
  1. Targeting microRNAs in cancer: rationale, strategies and challenges

    Authors: , , - Nature Reviews Drug Discovery 2010 cited by 1,494

  2. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B

    Authors: , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2007 cited by 1,666

  3. MicroRNAs in Cancer

    Authors: , , - Annual Review of Medicine 2009 cited by 1,781

  4. The dual epigenetic role of PRMT5 in acute myeloid leukemia: gene activation and repression via histone arginine methylation

    Authors: , , , , , , , , , , , , , , , , - Leukemia 2015 cited by 163

  5. A MicroRNA Signature of Hypoxia

    Authors: , , , , , , , , , , , - Molecular and Cellular Biology 2006 cited by 1,062

  6. ATF3 coordinates serine and nucleotide metabolism to drive cell cycle progression in acute myeloid leukemia

    Authors: , , , , , , , , , , , , , , , - Molecular Cell 2021 cited by 68

  7. MiR-15a and miR-16-1 cluster functions in human leukemia

    Authors: , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2008 cited by 806

  8. The long non-coding RNA HOXB-AS3 regulates ribosomal RNA transcription in NPM1-mutated acute myeloid leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Clara D. Bloomfield, Adrienne M. Dorrance, Ramiro Garzon - Nature Communications 2019 cited by 159

  9. A MicroRNA Signature Associated with Prognosis and Progression in Chronic Lymphocytic Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2005 cited by 2,412

  10. Acute Myeloid Leukemia: A Concise Review

    Authors: , - Journal of Clinical Medicine 2016 cited by 351

  11. MicroRNA expression and function in cancer

    Authors: , , , , - Trends in Molecular Medicine 2006 cited by 779

  12. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1

    Authors: , , , , , , , , , , , , , , , , , , , , , - Blood 2009 cited by 774

  13. Biological Functions of miR-29b Contribute to Positive Regulation of Osteoblast Differentiation

    Authors: , , , , , , , , , - Journal of Biological Chemistry 2009 cited by 590

  14. A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia

    Authors: , , , , , , , , , , , , , , , , , , - Blood 2017 cited by 153

  15. NF-κB–YY1–miR-29 Regulatory Circuitry in Skeletal Myogenesis and Rhabdomyosarcoma

    Authors: , , , , , , , , , , , - Cancer Cell 2008 cited by 589

  16. miR-328 Functions as an RNA Decoy to Modulate hnRNP E2 Regulation of mRNA Translation in Leukemic Blasts

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Cell 2010 cited by 569

  17. Poor Survival and Differential Impact of Genetic Features of Black Patients with Acute Myeloid Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2020 cited by 81

  18. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia

    Authors: , , , , , , , , , , , , , , , , , - Blood 2008 cited by 634

  19. Selective inhibition of nuclear export with selinexor in patients with non-Hodgkin lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , - Blood 2017 cited by 157

  20. Next-generation XPO1 inhibitor shows improved efficacy and in vivo tolerability in hematological malignancies

    Authors: , , , , , , , , , , , , , , , , , , , , , - Leukemia 2016 cited by 142

  21. DNA methylation epitypes highlight underlying developmental and disease pathways in acute myeloid leukemia

    Authors: , , , , , , , , , , , , , , , , , , , - Genome Research 2021 cited by 51

  22. CXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemia

    Authors: , , , , , - Journal of Clinical Investigation 2013 cited by 209

  23. Targeted Delivery of microRNA-29b by Transferrin-Conjugated Anionic Lipopolyplex Nanoparticles: A Novel Therapeutic Strategy in Acute Myeloid Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2013 cited by 193

  24. Aberrant Overexpression of IL-15 Initiates Large Granular Lymphocyte Leukemia through Chromosomal Instability and DNA Hypermethylation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2012 cited by 162